Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
Okazaki J, Tanahashi T, Sato Y, Miyoshi J, Nakagawa T, Kimura T, Miyamoto H, Fujino Y, Nakamura F, Takehara M, Ma B, Bando M, Kitamura S, Okamoto K, Muguruma N, Sogabe M, Takayama T. Okazaki J, et al. Among authors: kimura t. Digestion. 2020;101(6):794-806. doi: 10.1159/000503225. Epub 2019 Sep 27. Digestion. 2020. PMID: 31563901
High antitumor activity of pladienolide B and its derivative in gastric cancer.
Sato M, Muguruma N, Nakagawa T, Okamoto K, Kimura T, Kitamura S, Yano H, Sannomiya K, Goji T, Miyamoto H, Okahisa T, Mikasa H, Wada S, Iwata M, Takayama T. Sato M, et al. Among authors: kimura t. Cancer Sci. 2014 Jan;105(1):110-6. doi: 10.1111/cas.12317. Epub 2013 Dec 4. Cancer Sci. 2014. PMID: 24635824 Free PMC article.
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
Goji T, Kimura T, Miyamoto H, Takehara M, Kagemoto K, Okada Y, Okazaki J, Takaoka Y, Miyamoto Y, Mitsui Y, Matsumoto S, Sueuchi T, Tanaka K, Fujino Y, Takaoka T, Kitamura S, Okamoto K, Kimura M, Sogabe M, Muguruma N, Okahisa T, Sato Y, Sagawa T, Fujikawa K, Sato Y, Ikushima H, Takayama T. Goji T, et al. Among authors: kimura m, kimura t. Cancer Chemother Pharmacol. 2015 Sep;76(3):615-20. doi: 10.1007/s00280-015-2835-3. Epub 2015 Jul 29. Cancer Chemother Pharmacol. 2015. PMID: 26220846 Clinical Trial.
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
Tomonari T, Takeishi S, Taniguchi T, Tanaka T, Tanaka H, Fujimoto S, Kimura T, Okamoto K, Miyamoto H, Muguruma N, Takayama T. Tomonari T, et al. Among authors: kimura t. Oncotarget. 2016 Feb 9;7(6):7207-15. doi: 10.18632/oncotarget.6889. Oncotarget. 2016. PMID: 26769852 Free PMC article.
10,108 results
You have reached the last available page of results. Please see the User Guide for more information.